The Most Expensive Medical Treatment in America

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The Most Expensive Medical Treatment in America

© SDI Productions / Getty Images

Expensive medical treatments have been in the news recently. Medicare questioned whether it should reimburse the costs of a new Alzheimer’s drug. Aduhelm is costly, and there are questions about whether it is effective. It is also not considered safe by some medical experts. The New York Times described the controversy: “Last year, Medicare’s actuarial division, acting without knowing what the coverage decision would be, imposed one of the biggest-ever increases in Medicare Part B premiums for 2022, partly driven by the possibility of coverage for Aduhelm, which at the time was priced by its manufacturer at $56,000 a year.”

In a nutshell, the story shows the problem of how very expensive treatments are paid for. People may require them to stay alive or lead somewhat normal lives. But who should pay for them?

Certain conditions can be much more expensive to treat than others. To identify the most expensive ailment in America, 24/7 Tempo reviewed the cost per case dollars, which measures the amount of money spent per episode of care, for 256 detailed conditions treated in the United States in 2019 from the Health Care Satellite Account, a set of statistics measuring U.S. health care spending produced by the Bureau of Economic Analysis (BEA).

We used the bureau’s Blended Account database, which combines data from multiple sources, including large claims databases that cover millions of enrollees and billions of claims. To concentrate on specific conditions and diseases, we excluded miscellaneous categories, such as “Other care and screening.” Additional data also comes from the BEA.
[nativounit]
Although a few of these ailments, including some heart attacks and HIV, are known to be preventable, the majority of them are not. The causes of a wide range of cancers, as well as appendicitis and ulcerative colitis, are variable and poorly understood, meaning that patients may have little control over their progression and hence their need for expensive treatment.

Some of the most expensive ailments, including sickle cell anemia and cystic fibrosis, are hereditary conditions. While living a healthy lifestyle is a key factor in preventing certain medical conditions, it often has little to do with some of the costliest illnesses.

The most expensive medical treatment in America is for cystic fibrosis. Here are the details:

  • Cost per episode of care: $136,319
  • Annual expenditure on condition: $4,942,155,835 (185th most out of 256 conditions)
  • Annual weighted number of episodes: 36,254 (309th most)
  • Relative growth in cost per case spending: #1 fastest

[wallst_email_signup]
Click here to see all the most expensive medical treatments in America.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618